|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07H 19/10 | |
| A61K 31/7072 | |||
| A61P 31/14 |
| (11) | Patento numeris | 2940031 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 14760567.9 |
| Europos patento paraiškos padavimo data | 2014-03-06 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-11-04 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2017-09-27 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/CN2014/073004 |
| Data | 2014-03-06 |
| (87) | Numeris | WO 2014/135107 |
| Data | 2014-09-12 |
| (30) | Numeris | Data | Šalis |
| 201310075423 | 2013-03-08 | CN |
| (72) |
WANG, Yong, CN
ZHAO, Liwen, CN
ZHANG, Xian, CN
BI, Sheng, CN
GAO, Yiping, CN
CHEN, Hongyan, CN
WANG, Dezhong, CN
NAN, Yang, CN
ZHANG, Cang, CN
LI, Yuxiu, CN
ZHANG, Di, CN
|
| (73) |
Nanjing Sanhome Pharmaceutical Co., Ltd.,
Nanjing Economic and Technological Development Zone No. 9 Huizhong Road, Nanjing Jiangsu 210038,
CN
|
| (54) | NUCLEOSIDE PHOSPHORAMIDATE COMPOUNDS FOR USE IN THE TREATMENT OF HCV |
| NUCLEOSIDE PHOSPHORAMIDATE COMPOUNDS FOR USE IN THE TREATMENT OF HCV |